AUSTIN, TX (February 18, 2025) — Prodigy Health is pleased to announce Edward Zhu’s appointment to its Board of Directors. This appointment marks a significant step in strengthening the company's strategic direction and innovative leadership in the pharmaceutical distribution industry.
Mr. Zhu has over a decade of experience in financial strategy and private credit. Edward is the Head of Private Credit at A-CAP, where he leads A-CAP’s investment efforts in middle-market capital solutions.
Before A-CAP, Edward held several roles at Morgan Stanley, most recently in Capital Markets. Mr. Zhu has served on numerous boards of directors, including Nascent Technologies, KinderSystems, and La Roche Shipping. He is a Phi Beta Kappa graduate from Stanford University, where he earned an M.S. in Financial Mathematics and a B.A. in Economics. Edward also broadened his global perspective through the Bing Overseas Studies Program at the University of Oxford, focusing on History and Philosophy.
“Edward’s financial insight and visionary leadership make him an exceptional addition to our board,” said Ty Dishman, CEO. “We look forward to the fresh perspectives and strategic value he brings to our organization.”
Mr. Zhu joins Prodigy Health at a pivotal moment as the company continues to redefine healthcare delivery. His addition to the board underscores Prodigy Health’s commitment to integrating world-class financial expertise with its innovative, people-centered approach.
